[1] 汤群,欧强.PTX3在非酒精性脂肪肝患者血清中的表达及与肝纤维化评分的相关性.肝脏,2019,24:175-177. [2] Samuel VT,Shulman GI.Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases.Cell Metab,2018, 27:22-41. [3] Hudert CA,Tzschätzsch H,Guo J,et al.US time-harmonic elastography: detection of liver fibrosis in adolescents with extreme obesity with nonalcoholic fatty liver disease.Radiology,2018,288:99-106. [4] Africa JA,Behling CA,Brunt EM,et al.In children with nonalcoholic fatty liver disease, zone 1 steatosis is associated with advanced fibrosis.Clin gastroenterol hepatol,2018,16:438-446. [5] Koukias N,Buzzetti E,Tsochatzis EA.Intestinal hormones, gut microbiota and non-alcoholic fatty liver disease. Minerva Endocrinol,2017,42:184-194. [6] 《中华消化杂志》编委会,王兴鹏.肠道菌群失调诊断治疗建议.中华消化杂志,2009,29:335-337. [7] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南.中华内科杂志,2010,49:275-278. [8] 陈恬,秦琴,刘善荣.肠道菌群在肝病领域的研究现状及应用展望.中华检验医学杂志,2019,42:170-175. [9] 涂宏飞,费素娟.肠道微生态与非酒精性脂肪性肝病.肝脏,2018,23:347-349. [10] 盛国光.肝衰竭患者肠道微生态变化及其干预措施.中西医结合肝病杂志,2016,26:257-259. [11] Montazerifar F,Bakhshipour AR,Karajibani M,et al.Serum omentin-1, vaspin, and apelin levels and central obesity in patients with nonalcoholic fatty liver disease.J res med sci,2017,22:70. [12] 李晓玲,孙凤霞,隋京利,等.肠道微生态与胆汁淤积的关系.中国中西医结合消化杂志,2016,24:886-887,890. [13] 林睿.肠黏膜屏障损伤对自身免疫性肝炎患者枯否细胞免疫调节功能影响的研究.天津医科大学,2013. [14] 唐立.中国肠道微生态学研究的实践.胃肠病学和肝病学杂志,2019,28:241-244. [15] Yang NB,Ni SL,Li SS,et al.Endotoxin tolerance alleviates experimental acute liver failure via inhibition of high mobility group box 1.Int j clin exp pathol,2015,8:9062-9071. [16] 马姝丽,李小芹.益生菌辅助治疗对肝内胆汁淤积性肝炎患儿肠黏膜通透性及内毒素血症的影响.实用药物与临床,2018,21:666-669. [17] 葛文松,范建高,沈博,等.炎症性肠病与肝胆疾病的关系.中华肝脏病杂志,2013,21:12-14. [18] 任会娜,黄文祥.肠外营养相关性肝病的研究进展.中华肝脏病杂志,2017,25:557-560. |